Showing results (81-90 of 393) with videos related to

Sort By:
Pageof 40
The British Journal of Cancer. Supplement|March 1, 1975
Primary intestinal lymphoma and its relation to alpha heavy chain diseaseB Ramot, N Hulu
Medical and Pediatric Oncology|January 1, 1994
Hormonal treatment in pregnancy: a possible risk factor for neuroblastomaM Mandel, A Toren, G Rechavi, et al.
Hormone Research|January 1, 1984
Correlation between HbA1c, purified insulins, diabetic control, and insulin antibodies in diabetic childrenT Bistritzer, J Sack, R Theodor, et al.
Leukemia Research|October 23, 1998
The MACOP-B and VACOP-B combination chemotherapy for young patients with intermediate-grade non-Hodgkin's lymphomaJ Dreiher, O Shpilberg, P Raanani, et al.
The Journal of Laboratory and Clinical Medicine|May 1, 1975
Characterization of erythrocyte membrane-associated enzymes (glyceraldehyde-3-phosphate dehydrogenase and phosphoglyceric kinase)S L Schrier, I Ben-Bassat, I Junga, et al.
Harefuah|November 4, 2000
[High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer]A Avigdor, I Hardan, O Shpilberg, et al.
Clinical and Experimental Immunology|May 22, 2001
Activation of human monocytes/macrophages by hypo-osmotic shockO Frenkel, E Shani, I Ben-Bassat, et al.
Israel Journal of Medical Sciences|August 1, 1988
HTLV-I-associated T-cell leukemia/lymphoma in IsraelJ Leor, P Langevitz, H Trau, et al.
Archives of Internal Medicine|August 1, 1989
Evaluation of an intervention aimed at reducing inappropriate use of preoperative blood coagulation testsB Mozes, D Lubin, B Modan, et al.
British Journal of Haematology|February 26, 2000
Therapy with thalidomide in refractory multiple myeloma patients - the revival of an old drugA Kneller, P Raanani, I Hardan, et al.
Pageof 40